Breaking News
September 26, 2018 - New insights into what drives organ transplant rejection
September 26, 2018 - Tiny Device Is a ‘Huge Advance’ for Treatment of Severe Heart Failure
September 26, 2018 - Research shows possibility to postpone cumbersome treatment for low-risk MDS patients
September 26, 2018 - CSU chemists may help in making extracorporeal life support devices more effective
September 26, 2018 - Blood-brain barrier can be important biomarker for early diagnosis of Alzheimer’s disease
September 26, 2018 - PCORI, AHRQ announce awards to support patient-centered outcomes research in learning health systems
September 26, 2018 - Scientists discover and characterize human skeletal stem cells
September 26, 2018 - Repeat CT Common in Peds Traumatic Epidural Hematoma
September 26, 2018 - Genetics Home Reference: bunion
September 26, 2018 - Increase observed in hearts from drug-intoxicated donors
September 26, 2018 - For Heart Failure Patients, Mitral Valve Procedure Improved Outcomes
September 26, 2018 - TINY cancer detection device shows promise as point-of-care detector of KSHV
September 26, 2018 - Women with non-small cell lung cancers live longer than their male counterparts
September 26, 2018 - KTU researchers engineer experimental bone to help treat osteoarthritis patients
September 26, 2018 - Foundation for a Smoke-Free World calls for proposals to implement Smoke-Free Index
September 26, 2018 - Functional Imagery Training helps lose five times more weight than talking therapy
September 26, 2018 - Fewer American Teens Having Sex, Most Using Birth Control
September 26, 2018 - We are predisposed to forgive, new research suggests
September 26, 2018 - Insomnia Exacts Heavy Toll on Quality of Life
September 26, 2018 - Clinical study shows efficacy, safety of novel drug-eluting stent with improved radiographic visibility
September 26, 2018 - Cytox, AIBL announce expanded agreement to assess genetic risk for Alzheimer’s
September 26, 2018 - Study finds persistent rate of lawnmower injury-related emergency department visits
September 26, 2018 - Researchers find molecule that halts, reverts neurodegeneration caused by Parkinson’s disease
September 26, 2018 - Novartis announces winners of 2018 eXcellence in Ophthalmology Vision Award
September 26, 2018 - New spinout company to tackle drug-resistant infections with novel antibiotics
September 26, 2018 - In depression the brain region for stress control is larger
September 26, 2018 - Smuggling RNA into cells can activate the immune system to fight cancer
September 26, 2018 - Special Focus Issue takes wide view of complementary and integrative medicine in cancer
September 26, 2018 - Researchers now confirm that genome duplication drives evolution of species
September 25, 2018 - Study provides evidence of beta lactamase producing, antimicrobial resistant E. coli in U.S. retail meat
September 25, 2018 - UCI study finds new cause of cerebral microbleeds
September 25, 2018 - Researchers propose mechanism by which ASTN2 protein defects lead to brain disorders
September 25, 2018 - Chinese and German researchers to cooperate more closely in future for better food
September 25, 2018 - Recent study helps predict probability of pregnant mothers to have child with autism
September 25, 2018 - New online, sound matching tool offers tinnitus sufferers potential treatment options
September 25, 2018 - UC Davis researchers take critical step in developing more effective Salmonella vaccine
September 25, 2018 - Antibiotics best paediatric treatment for children’s chronic wet cough
September 25, 2018 - Looking beyond opioids: Stanford pain psychologist briefs Congress
September 25, 2018 - Organs actively fighting back against autoimmune diseases, finds study
September 25, 2018 - Lancaster professor aims to understand how genes affect smoking cessation
September 25, 2018 - Human-oriented perspective needed to better understand Parkinson’s disease
September 25, 2018 - Physical activity may have beneficial effects for people with rare Alzheimer’s disease
September 25, 2018 - FDA Updates on Valsartan Recalls
September 25, 2018 - 3-D-printed tracheal splints used in groundbreaking pediatric surgery
September 25, 2018 - Who is the designated driver, or proxy, for your health decisions?
September 25, 2018 - New chemo-optogenetic method enables multi-directional activity control of cellular processes
September 25, 2018 - Study explores link between genetic predisposition to Alzheimer’s and cardiometabolic risk factors
September 25, 2018 - NeoTract presents new clinical data from studies of UroLift System for patients with BPH
September 25, 2018 - Patients with paralysis manage to walk thanks to new technology
September 25, 2018 - Statins Improve Long-Term Survival After AAA Repair
September 25, 2018 - Novel brain network linked to chronic pain in Parkinson’s disease
September 25, 2018 - Researchers reassess negative pressure wound therapy as its benefit and harm remain unclear
September 25, 2018 - Older adults with ‘fall plan of care’ less likely to suffer fall-related hospitalizations
September 25, 2018 - FDA lifts partial clinical hold that paused enrollment of new patients in tazemetosta clinical trials
September 25, 2018 - IME Medical Electrospinning establishes state-of-the-art manufacturing lab facilities
September 25, 2018 - Phase 1 and 2 clinical trials of entrectinib drug in ROS1-positive NSCLC show promising results
September 25, 2018 - How to Protect Your Eyesight
September 25, 2018 - Novel approach allows researchers to define how cells in the retina respond to diabetes
September 25, 2018 - Columbia University announces winners of 2018 Louisa Gross Horwitz Prize
September 25, 2018 - New model enables anyone to run powerful simulations, complex calculations easily
September 25, 2018 - Clinical trial investigators found non-compliant with requirement to report results on EU register
September 25, 2018 - Study analyzes quality of protein supplements in function of source, treatment and storage
September 25, 2018 - FDA grants Orphan Drug Designation to Myelo001 for treatment of Acute Radiation Syndrome
September 25, 2018 - U.S. Alzheimer’s Cases to Nearly Triple by 2060
September 25, 2018 - Improving cell replacement therapy for Parkinson’s disease
September 25, 2018 - Genervon reports new findings that drug candidate GM6 attenuates Alzheimer’s disease in mice model
September 25, 2018 - FDA approves new 5 mm diameter drug-eluting stent from Cook Medical
September 25, 2018 - New $17.8 million grant ensures USC at forefront of research on tobacco-related health risks
September 25, 2018 - Researchers analyze response to combination immunotherapy for patients with rare skin cancer
September 25, 2018 - Study sheds light on how brain protein may be involved neurodevelopmental disorders
September 25, 2018 - Where to draw the line on incentives
September 25, 2018 - Solid fuel use linked with increased risk of hospitalization or death from respiratory diseases
September 25, 2018 - ‘Trouble Brewing’ report highlights steps that governments can take to reduce alcohol-related harms
September 25, 2018 - Recurrence risk of VTE appears similar for patients with cancer and those with unprovoked VTE
September 25, 2018 - Global leaders must make bold commitments at first-ever UN tuberculosis summit
September 25, 2018 - Brief sleep intervention works long-term to prevent child obesity
September 25, 2018 - Vaping among kids and teens a growing concern
September 25, 2018 - Public launch of products and application solutions from Porvair Laboratory Division
September 25, 2018 - Harmful H. pylori may play a role in Parkinson’s disease
September 25, 2018 - Researchers develop way to measure different types of fear of falling in patients with Parkinson’s
Colon Ca: Elevated Preop CEA Not Indicative of Poor Prognosis

Colon Ca: Elevated Preop CEA Not Indicative of Poor Prognosis

image_pdfDownload PDFimage_print

Action Points

  • Note that this single-center observational study found that a normal post-operative CEA was as “protective” as a normal pre-operative CEA in patients with non-metastatic colon cancer.
  • This argues that routine preoperative CEA measurement may offer little information in terms of ultimate prognosis.

Elevated preoperative carcinoembryonic antigen (CEA) that normalizes after colon cancer surgery is not an indicator of poor prognosis, researchers reported.

Although current guidelines recommend measuring preoperative CEA in patients with colon cancer, the investigators said that considering the results of their study, they now question the utility of that approach and think it would be wiser to emphasize postoperative CEA instead.

The study, by Tsuyoshi Konishi, MD, PhD, of Memorial Sloan Kettering Cancer Center in New York City, and colleagues, was published in JAMA Oncology.

CEA is a colorectal cancer marker that the National Comprehensive Cancer Network, the American Society of Clinical Oncology, and the European Group on Tumour Markers all recommend be measured preoperatively in patients with nonmetastatic colon cancer.

For the study Konishi et al explained that the aim was to determine whether preoperative or postoperative CEA is more prognostic, and, more specifically, whether patients with elevated CEA that normalizes after resection have the same risk of recurrence as that of patients with normal preoperative CEA.

The retrospective cohort analysis included 1,027 patients (461 males, median age of 64) from a comprehensive cancer center who underwent curative resection for stages I to III colon adenocarcinoma between January 2007 and December 2014.

Preoperative CEA was normal in 715 patients (69.6%) and elevated in 312 (30.4%). Of the 312 with elevated preoperative CEA, 199 patients had postoperative CEA data available, and 142 of these had normalized postoperative CEA levels and 57 had elevated postoperative levels.

The patients were divided in three groups according to CEA status:

  • Patients with normal (≤5.0 ng/mL) preoperative CEA (normal preoperative group)
  • Patients with elevated (>5.0 ng/mL) preoperative CEA but normal postoperative CEA (normalized postoperative group)
  • Patients whose preoperative and postoperative CEA levels were both elevated (elevated postoperative group)

Patients with normal preoperative CEA had a 7.4% higher 3-year recurrence-free survival (RFS) than the combined cohorts with elevated preoperative CEA, but had RFS comparable to that of patients with normalized postoperative CEA. Patients with elevated postoperative CEA had “significantly” lower 3-year RFS (14.9%) than the combined cohorts with normal postoperative CEA.

The hazard function for each group indicated that the risk of recurrence was higher and peaked earlier in patients in the elevated postoperative CEA group.

A univariate analysis showed that older age, the presence of lymphovascular invasion, higher tumor-nodes-metastasis (TNM) staging, and elevated postoperative CEA were all associated with shorter RFS.

Multivariate analyses showed that elevated postoperative CEA (HR, 2.0; 95% CI 1.1 to 3.5), was independently associated with shorter RFS as well as with higher TNM stage, older age, and presence of lymphovascular invasion, while normalized postoperative CEA (HR, 0.77; 95% CI 0.45 to 1.30) was not.

“These findings suggest that with regard to prognosis, measuring postoperative rather than preoperative CEA is more instructive,” the researchers concluded.

Elevated postoperative CEA often normalizes after surgery and these patients have outcomes similar to those of patients with normal preoperative CEA. As a result, the team wrote, emphasis should be placed on postoperative CEA. Furthermore, since patients with elevated postoperative CEA tend to experience recurrence early, risk-adjusted and individualized surveillance strategies should be considered.

Writing in an accompanying commentary, Rebecca Anne Miksad, MD, MPH, director of Gastrointestinal Oncology at Beth Israel Deaconess Medical Center in Boston, and Neal J. Meropol, MD, division chief of Hematology and Oncology at University Hospitals Cleveland Medical Center Case Comprehensive Cancer Center, said: “This study highlights the potential of real-world evidence to contribute insights that might ultimately lead to changes in clinical guidelines and standards of care.”

Miksad and Meropol noted that the weaknesses of the study — such as generalizability, potential selection biases, and inconsistency and attrition in follow-up — were typical for an observational study that included cohorts of patients from a single institution, but the results lay important groundwork for additional research. Furthermore, the editorial states, getting corroborative evidence from other real-world settings could justify changes in clinical practice recommendations without the need to go through a prospective randomized trial.

The research was funded in part by the National Institutes of Health/National Cancer Institute.

Konishi and co-authors reported having no conflicts of interest.

Miksad and Meropol reported being employees of Flatiron Health in New York City.

  • Reviewed by
    F. Perry Wilson, MD, MSCE Assistant Professor, Section of Nephrology, Yale School of Medicine and Dorothy Caputo, MA, BSN, RN, Nurse Planner

2017-12-22T13:00:00-0500

Tagged with:

About author

Related Articles